Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Brian C. Miller, Debattama R. Sen, Rose Al Abosy, +24

Nature Immunology

Mediate Tumor ControlCancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint Inhibitor +6

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance

Catherine L. Tan, Juhi R. Kuchroo, Peter T. Sage, +15

The Journal of Experimental Medicine

B-cell-specific checkpoint molecules that regulate anti-tumour immunity

Lloyd Bod, Yoon-Chul Kye, Jingwen Shi, +24

Nature

Cancer ImmunosurveillanceB-cell-specific Checkpoint MoleculesImmunologyTumor ImmunityImmune Checkpoint Inhibitor +3

Lack of TIM-3 Immunoregulation in Multiple Sclerosis

Yang Li, David E. Anderson, Juhi R. Kuchroo, +1

The Journal of Immunology

Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment

Kristen E. Pauken, Osmaan Shahid, Kaitlyn A. Lagattuta, +18

The Journal of Experimental Medicine

T-regulatory CellImmunologyPathologyImmunophenotypingImmunotherapy +14

PD-L1–PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection

Joseph A. Perry, Lindsey A. Shallberg, Joseph T. Clark, +16

Nature Immunology

Pd-l1–pd-1 InteractionsAutoimmune DiseaseT-regulatory CellImmune RegulationImmunology +9

Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer

Leah L. Thompson, Nira A. Krasnow, Michael S. Chang, +10

JAMA Dermatology

Severity of innate immune-mediated colitis is controlled by the cytokine deficiency-induced colitis susceptibility-1 ( <i>Cdcs1</i> ) locus

Joerg Ermann, Wendy S. Garrett, Juhi R. Kuchroo, +4

Proceedings of the National Academy of Sciences

Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity

Leah L. Thompson, E.B. Li, Nira A. Krasnow, +12

British Journal of Dermatology